Effects of (-)-epigallocatechin gallate combined with on Paclitaxel theproliferation and apoptosis of human lung cancer cell line A549

WANG Jianghong; XU Li; DONG Yang; GUO Shuliang

您当前的位置：

首页 >

文章列表页 >

Effects of (-)-epigallocatechin gallate combined with on Paclitaxel theproliferation and apoptosis of human lung cancer cell line A549

更新时间：2023-12-18

- Effects of (-)-epigallocatechin gallate combined with on Paclitaxel theproliferation and apoptosis of human lung cancer cell line A549
- Journal of Chongqing Medical University Vol. 37, Issue 4, Pages: 306-310(2012)
- 作者机构：
  
  重庆医科大学附属第一医院呼吸内科,重庆,400016
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2012，
扫描看全文
WANG Jianghong, XU Li, DONG Yang, et al. Effects of (-)-epigallocatechin gallate combined with on Paclitaxel theproliferation and apoptosis of human lung cancer cell line A549. [J]. Journal of Chongqing Medical University 37(4):306-310(2012)
DOI：

WANG Jianghong, XU Li, DONG Yang, et al. Effects of (-)-epigallocatechin gallate combined with on Paclitaxel theproliferation and apoptosis of human lung cancer cell line A549. [J]. Journal of Chongqing Medical University 37(4):306-310(2012) DOI：

摘要

目的：研究表没食子儿茶素没食子酸酯［(-)-Epigallocatechin gallate

EGCG］及紫杉醇单独使用和联合使用时对肺癌A549细胞的形态、活性、细胞凋亡以及相关信号通路的影响。方法：不同浓度的EGCG、紫杉醇单用及联合应用在不同时间作用于肺癌A549细胞，用细胞集落形成实验检测细胞活力、WST-1法检测细胞增殖能力、Hoechst-33342荧光法检测细胞凋亡的情况、流式细胞仪检测细胞凋亡率、Western blot检测内质网应激标志蛋白GRP78表达。结果：①EGCG和紫杉醇均能抑制肺癌A549细胞的增殖；EGCG与紫杉醇联合的抑制率高于单用EGCG或紫杉醇组（P＜0.05）。②EGCG和紫杉醇均可诱导细胞凋亡，2种药物联用后，诱导细胞凋亡作用显著增强。③蛋白免疫印迹实验显示EGCG和紫杉醇联合可能是通过内质网应激信号通路发挥作用。结论：EGCG、紫杉醇均可抑制人肺癌A549细胞的增殖、诱导细胞的凋亡，两者联合应用具有协同作用，能显著增强细胞凋亡作用。

Abstract

Objective:To study the effects of combined and exclusive application of (-)-epigallocatechin gallate (EGCG) and Paclitaxel on the morphology

activity

apoptosis and possible signal pathway of human lung cancer cell line A549.Methods:EGCG and Paclitaxel with different concentrations were applied to human lung cancer cell line A549 exclusively and in combination at different periods.The cell activity was examined by cell colony formation assay

cell proliferation by WST-1 assay

cell apoptosis by Heochst-33342 test

apoptosis rate by flow cytometry and expressions of GRP78 by western blot.Results:Both EGCG and Paclitaxel can inhibit the proliferation of lung cancer cell line A549.The inhibiting effect was more obvious if the two drugs were used in combination (P<0.05).Both EGCG and Paclitaxel can induce the apoptosis of lung cancer cell line A549.The inducing effect was more obvious if the two drugs were used in combination.The results of western blot indicated that the two drugs may exert the effects through endoplasmic reticulum stress signal pathways.Conclusion:Both EGCG and Paclitaxel can inhibit the proliferation and induce the apoptosis of A549 cells

more obvious effects can be achieved if the two drugs are used in combination.

关键词

表没食子儿茶素没食子酸酯紫杉醇肺癌凋亡

Keywords

(-)-epigallocatechin gallatepaclitaxellung cancerapoptosis

references

Views

1071

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Glycyrrhiza uralensis Fisch. endophytes combined with cisplatin on proliferation and apoptosis of A549 cells

Establishment and validation prediction models of benign and malignant predictors for solitary pulmonary nodules

Clinical analysis of dermatomyositis/polymyositis complicated with lung disease

Effect of progressive muscle relaxation training on coping style and emotion of patients with lung cancer

Chronic obstructive pulmonary diseases and risk of lung cancer among nonsmokers:a systematic review

Related Author

Zhang Shanglong

Zhang Nan

Lian Xiaolong

Ye Liqiao

Ma Quhuan

Deng Yi

Zhu Xiaoqian

Zheng Li

Related Institution

College of Pharmacy，Gansu University of Chinese Medicine

Department of Respiratory and Critical Care Medicine, Chongqing Medical University

Department of Respiratory,The First Affiliated Hospital of Chongqing Medical University

Department of Clinic Nursing,Xiangya Nursing School of Central South University

Department of Respiratory,the Second Affiliated Hospital,Chongqing Medical University

⁰